3+ hour, 36+ min ago  (261+ words) Cancer World shared a post on Linked In: "Cancer World Issue #116 (June 2026) is live! We tend to talk about cancer in the language of progress-new therapies, wider prevention, smarter models of care. It is a comforting vocabulary. It is also…...

12+ hour, 34+ min ago  (58+ words) Janne Lehti, Professor at Karolinska Institutet, Scientific Director of Sci Life Lab shared a post on Linked In: "Probably the two best posters with most knowledgeable presenters at this year's EACR conference. Then again, I might be biased." Other articles…...

1+ day, 1+ hour ago  (137+ words) Open Doors, Drs. Ioanna and Vilma Podcast shared a post on Linked In: "The Open Doors Podcast is delighted to share our latest blog featuring Professor Rob Jones, now published on the Dr Executive Coach blog. Rob explores a range…...

1+ day, 1+ hour ago  (293+ words) Oliver Bogler, Chief Executive Officer of Night Science Institute and Strategic Advisor at Barnacle Labs, shared a post on Linked In: "Six years of my career, I worked in a different state from my family. Not because I wanted to....

1+ day, 2+ hour ago  (185+ words) Juliane Winkler, Group Leader at Center for Cancer Research at Medical University of Vienna, shared a post on Linked In: "The last 4 days at EACR2026 in Budapest were a blast! Here are my 6 highlights " I was particularly excited to listen to…...

1+ day, 15+ hour ago  (75+ words) Jordan Abbott, Dermatologist, Co-founder of Physicians Invest, shared a post on'X: "Physicians are not burned out because medicine is hard. Medicine has always been hard. That is not new. We are burned out because the things making it harder have…...

1+ day, 18+ hour ago  (227+ words) Sachin H. Jain, President and CEO, Board Director at SCAN Health Plan, shared on'Linked In: Today, we have more pricing information than ever before. The question is no longer whether prices should be transparent. The question is: what do we do…...

1+ day, 23+ hour ago  (124+ words) Onco Daily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest…...

2+ day, 8+ hour ago  (634+ words) However, not all patients may derive the same level of benefit from treatment intensification. Abiraterone can add toxicity, treatment burden, and cost, creating a need for biomarkers that can better identify patients most likely to benefit. A new post-hoc biomarker…...

3+ day, 14+ hour ago  (270+ words) A common sub-analysis in clinical trials is the association of the type of response with survival outcomes, often showing that responders tend to do better. One issue with these analyses is that the causation is often misinterpreted. Patients are implied…...